Labat Africa Ltd Market Cap ($5.05 Million)
Market Cap & Net Worth: Labat Africa Ltd (LAB)
Labat Africa Ltd market cap. Labat Africa Ltd (JSE:LAB) has a market capitalization of $5.05 Million (ZAC9.50 Billion) as of November 7, 2026. Listed on the JSE stock exchange, this South Africa-based company holds position #28473 globally and #216 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Labat Africa Ltd's stock price ZAC3.00 by its total outstanding shares 3165108879 (3.17 Billion). Also see Labat Africa Ltd cash flow conversion for how efficiently the company converts equity into cash flow.
Labat Africa Ltd Market Cap History (2015–2026)
Labat Africa Ltd market cap history from 2015 to 2026. Data shows change from $252.31 Million to $5.05 Million (-29.57% CAGR). Check LAB live share price for real-time trading data and today's change.
Labat Africa Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Labat Africa Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Labat Africa Ltd growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.07x
Labat Africa Ltd's market cap is 0.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.11x
Labat Africa Ltd's market cap is 0.11 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $47.10 Million | $14.31 Million | $8.40 Million | 3.29x | 5.61x |
| 2017 | $63.92 Million | $52.01 Million | $4.64 Million | 1.23x | 13.77x |
| 2018 | $65.60 Million | $73.35 Million | $12.58 Million | 0.89x | 5.21x |
| 2019 | $68.97 Million | $616.43 Million | -$72.94 Million | 0.11x | N/A |
| 2020 | $72.33 Million | $40.25 Million | $946.00K | 1.80x | 76.46x |
| 2021 | $48.78 Million | $29.27 Million | -$22.75 Million | 1.67x | N/A |
| 2022 | $16.82 Million | $30.72 Million | -$48.11 Million | 0.55x | N/A |
| 2023 | $11.77 Million | $49.53 Million | -$86.90 Million | 0.24x | N/A |
| 2024 | $11.77 Million | $48.54 Million | -$25.80 Million | 0.24x | N/A |
| 2025 | $13.46 Million | $199.40 Million | $117.87 Million | 0.07x | 0.11x |
Competitor Companies of LAB by Market Capitalization
Companies near Labat Africa Ltd in the global market cap rankings as of November 7, 2026. Also see LAB total asset value for a full breakdown of the balance sheet.
Key companies related to Labat Africa Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #506 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #532 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #570 globally with a market cap of $46.85 Billion USD ( CN¥320.16 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #615 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #506 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #532 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $47.40 |
| #570 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.85 Billion | CN¥50.19 |
| #615 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €19.30 |
Market Capitalization of Labat Africa Ltd (2015–2026)
Market capitalization of Labat Africa Ltd from 2015 to today. Between 2015 and today, Labat Africa Ltd's market cap moved from $252.31 Million to $ 5.05 Million, with a yearly change of -29.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ZAC5.05 Million | -62.50% |
| 2025 | ZAC13.46 Million | +14.29% |
| 2024 | ZAC11.77 Million | 0.00% |
| 2023 | ZAC11.77 Million | -30.00% |
| 2022 | ZAC16.82 Million | -65.52% |
| 2021 | ZAC48.78 Million | -32.56% |
| 2020 | ZAC72.33 Million | +4.88% |
| 2019 | ZAC68.97 Million | +5.13% |
| 2018 | ZAC65.60 Million | +2.63% |
| 2017 | ZAC63.92 Million | +35.71% |
| 2016 | ZAC47.10 Million | -81.33% |
| 2015 | ZAC252.31 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 6th, 2026 the market cap of Labat Africa Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.05 Million USD |
| MoneyControl | $5.05 Million USD |
| MarketWatch | $5.05 Million USD |
| marketcap.company | $5.05 Million USD |
| Reuters | $5.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Labat Africa Ltd
Labat Africa Limited, an investment holding company, engages in the technology, logistics, and healthcare activities in South Africa. The company operates through Technology, Logistics, and Healthcare segments. It engages in the manufacture and distribution of integrated circuits, including micro electronic systems; transportation of coals and minerals for mines; and sale of medical cannabis, as … Read more